Form 4: BioCardia CEO Peter Altman Buys 1,000 Shares of Common Stock
SEC Form 4
BioCardia's President and CEO, Peter Altman, recently purchased 1,000 shares of the company's common stock at an average price of $3.36 per share.
Summary
- On June 10, 2024, Peter Altman, the President and CEO of BioCardia, Inc., purchased 1,000 shares of BioCardia's common stock.
- The purchase was made at a weighted average price of $3.36 per share, with individual trades ranging from $3.31 to $3.40.
- Following this transaction, Altman directly owns 38,245 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase is a good sign, but it's a small transaction and doesn't provide a comprehensive view of the company's health.
Positives
- The CEO's purchase of company stock may signal confidence in BioCardia's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of the transaction where Peter Altman purchased 1,000 shares of BCDA common stock. |
| 06/12/2024 | Date of signature on the SEC Form 4 filing. |
Keywords
BioCardia, BCDA, Insider Trading, Stock Purchase, Peter Altman, CEO, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.